The Clinical Outcome of Chemotherapy-Induced Amenorrhea in Premenopausal Young Patients with Breast Cancer with Long-Term Follow-up

By Jung Minkyu  

Annals of Surgical Oncology, Vol. 17, Iss. 12, 2010-12 ,pp. : 3259-3268

Springer Publishing Company

Access to resources Recommend Favorite

Incidence and predictors of ovarian function recovery (OFR) in breast cancer (BC) patients with chemotherapy-induced amenorrhea (CIA) who switched from tamoxifen to exemestane

By Guerrero A.   Gavil J.   Folkerd E.   Ortiz B.   Martnez F.   Garca A.   Climent M. A.   Guillem V.   Ruz A.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 674-679

Oxford University Press

Access to resources Recommend Favorite

Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment

By Vehmanen L.   Saarto T.   Elomaa I.   Makela P.   Valimaki M.   Blomqvist C.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2373-2378

Elsevier

Access to resources Recommend Favorite

Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications

By del Mastro L.   Venturini M.   Roberto Sertoli M.   Rosso R.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 2, 1997-04 ,pp. : 183-190

Springer Publishing Company

Access to resources Recommend Favorite

Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysis

By Petrelli Fausto  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 335-346

Springer Publishing Company

Access to resources Recommend Favorite